We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+0.22%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$412M
AUM Growth
-$24.9M
Cap. Flow
-$20.3M
Cap. Flow %
-4.93%
Top 10 Hldgs %
62.81%
Holding
32
New
1
Increased
17
Reduced
13
Closed
1

Top Buys

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$5.9M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$5.76M
3
BMY icon
Bristol-Myers Squibb
BMY
+$5.07M
4
BIIB icon
Biogen
BIIB
+$4.92M
5
CNC icon
Centene
CNC
+$3.82M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$15.5M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$11.3M
3
CI icon
Cigna
CI
+$7.37M
4
BSX icon
Boston Scientific
BSX
+$6.24M
5
ELV icon
Elevance Health
ELV
+$5.71M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$167B
$45M 10.92%
542,773
-53,263
-9% -$4.41M
INCY icon
2
Incyte
INCY
$23.4B
$31.2M 7.57%
432,235
+20,748
+5% +$1.62M
BMY icon
3
Bristol-Myers Squibb
BMY
$124B
$31.2M 7.55%
449,571
+71,902
+19% +$5.07M
CAH icon
4
Cardinal Health
CAH
$53.5B
$28.4M 6.9%
376,701
+22,829
+6% +$1.72M
MDT icon
5
Medtronic
MDT
$106B
$25.7M 6.23%
318,904
+41,469
+15% +$3.38M
BIIB icon
6
Biogen
BIIB
$30.4B
$24.4M 5.92%
87,836
+17,797
+25% +$4.92M
ZBH icon
7
Zimmer Biomet
ZBH
$17.6B
$22.8M 5.52%
176,103
+21,987
+14% +$2.76M
LH icon
8
Labcorp
LH
$23.2B
$18.7M 4.53%
94,767
+8,054
+9% +$1.66M
ELV icon
9
Elevance Health
ELV
$80.9B
$16.5M 3.99%
35,779
-11,998
-25% -$5.71M
BMRN icon
10
BioMarin Pharmaceuticals
BMRN
$11.5B
$15.2M 3.69%
156,350
+1,341
+0.9% +$139K
CNC icon
11
Centene
CNC
$32.8B
$15.1M 3.66%
238,746
+53,845
+29% +$3.82M
EW icon
12
Edwards Lifesciences
EW
$49.4B
$13.1M 3.19%
158,806
-15,446
-9% -$1.21M
BRKR icon
13
Bruker
BRKR
$8.86B
$12.1M 2.93%
153,117
-38,865
-20% -$2.8M
QGEN icon
14
Qiagen
QGEN
$8.49B
$12M 2.9%
245,937
+25,759
+12% +$1.31M
CTLT
15
DELISTED
CATALENT, INC.
CTLT
$9.89M 2.4%
150,501
+95,501
+174% +$5.9M
THC icon
16
Tenet Healthcare
THC
$16.8B
$9.82M 2.38%
165,227
-30,727
-16% -$1.71M
NUVA
17
DELISTED
NuVasive, Inc.
NUVA
$9.66M 2.34%
233,756
+59,914
+34% +$2.56M
BSX icon
18
Boston Scientific
BSX
$65.4B
$8.12M 1.97%
162,397
-132,387
-45% -$6.24M
SGEN
19
DELISTED
Seagen Inc. Common Stock
SGEN
$7.29M 1.77%
36,000
-70,207
-66% -$11.3M
BAX icon
20
Baxter International
BAX
$11.7B
$6.77M 1.64%
167,000
-54,088
-24% -$2.29M
BIO icon
21
Bio-Rad Laboratories Class A
BIO
$8.15B
$6.52M 1.58%
13,617
-2,371
-15% -$1.11M
MRK icon
22
Merck
MRK
$315B
$5.97M 1.45%
56,153
-143,147
-72% -$15.5M
ILMN icon
23
Illumina
ILMN
$28.2B
$5.51M 1.33%
24,340
-24,490
-50% -$5.01M
ALNY icon
24
Alnylam Pharmaceuticals
ALNY
$35.7B
$5.49M 1.33%
+27,389
New +$5.76M
IONS icon
25
Ionis Pharmaceuticals
IONS
$8.99B
$5.23M 1.27%
146,441
+5,068
+4% +$190K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2023 Portfolio in Review

As of Q1 2023, Sector Gamma AS held 32 positions worth $412M, down 5.7% from $437M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Sector Gamma AS withdrew a net $20.3M in Q1 2023, closing 1 position and reducing 13 holdings. Its most notable exit was Cigna, an estimated $7.37M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Alnylam Pharmaceuticals worth $5.49M.

  • Sector Gamma AS's largest Q1 2023 buy was Alnylam Pharmaceuticals: 27,389 shares worth $5.49M.
  • Sector Gamma AS added most to CATALENT, INC. in Q1 2023, an estimated $5.9M increase.
  • Sector Gamma AS's biggest Q1 2023 reduction was Merck, cutting an estimated $15.5M.
  • Sector Gamma AS fully exited Cigna in Q1 2023, selling an estimated $7.37M.
  • Sector Gamma AS's ten largest holdings make up 63% of its $412M portfolio in Q1 2023.
  • Sector Gamma AS opened 1 new position and closed 1 in Q1 2023.
  • Sector Gamma AS's portfolio value fell 5.7% quarter-over-quarter to $412M.

Based on Sector Gamma AS's 13F filing for Q1 2023, filed 12 May 2023.